Biohaven Pharmaceutical Holding Company Ltd.
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.24 USD | +10.24% | -17.99% | -75.47% |
01:51pm | Biohaven Insider Bought Shares Worth $1,002,470, According to a Recent SEC Filing | MT |
May. 10 | Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-75.47% | 541M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- BHVN Stock
- News Biohaven Pharmaceutical Holding Company Ltd.
- Biohaven Granted US FDA Fast Track Designation for Spinal Muscular Atrophy Treatment Candidate